University of Kentucky

UKnowledge
Plant and Soil Sciences Faculty Patents

Plant and Soil Sciences

3-6-2007

Plant Cells and Plants Expressing Chemeric Isoprenoid Synthases
Joseph Chappell
University of Kentucky, chappell@uky.edu

Kyoungwhan Back
University of Kentucky

Follow this and additional works at: https://uknowledge.uky.edu/pss_patents
Part of the Plant Sciences Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Recommended Citation
Chappell, Joseph and Back, Kyoungwhan, "Plant Cells and Plants Expressing Chemeric Isoprenoid
Synthases" (2007). Plant and Soil Sciences Faculty Patents. 37.
https://uknowledge.uky.edu/pss_patents/37

This Patent is brought to you for free and open access by the Plant and Soil Sciences at UKnowledge. It has been
accepted for inclusion in Plant and Soil Sciences Faculty Patents by an authorized administrator of UKnowledge.
For more information, please contact UKnowledge@lsv.uky.edu.

US007186891B1

(12) United States Patent

(10) Patent N0.:
(45) Date of Patent:

Chappell et al.

US 7,186,891 B1
*Mar. 6, 2007

PLANT CELLS AND PLANTS EXPRESSING

Ave et al., “Aphid repellent sesquiterpenes in glandular

CHIMERIC ISOPRENOID SYNTHASES

trichomes of Solanum berthaultii and S. tuberosum,” Ento

(75) Inventors: Joseph Chappell, Lexington, KY (US);

Back et al., “Expression of a Plant Sesquiterpene Cyclase
Gene in Escherichia coli,” Arch. Biochem. Biophys.

(54)

mologia Experimentalis et Applicata 44:l3l*l38 (1987).

KyoungWhan Back, Kwangju (KR)
(73) Assignee: University of Kentucky, Research
Foundation, Lexington, KY (US)
(*)

Notice:

Subject to any disclaimer, the term of this
patent is extended or adjusted under 35

This patent is subject to a terminal dis
claimer.

(21) Appl. No.: 09/514,513

teroids and Prothoracicotropic HormoneiLike Activity in
Heliothis I/irescens (Fabr.) Larvae,” J. Insect. Physiol.
36:125*131 (1990).
Borman, “Scientists Mobilize to Increase Supply of Anti
cancer Drug Taxol,” Chemical & Engineering News 11*18

(1991).
Cane et al. “Partial Puri?cation and Characterization of

Division of application No. 09/134,699, ?led on Aug. 14,
1998, now Pat. No. 6,072,045, which is a division of

application No. 08/631,341, ?led on Apr. 12, 1996, now Pat.
No. 5,824,774.

(51)

270:7375i738l (1995).

Bowers et al., “Sesquiterpene Progenitor, Germacrene A: An
Alarm Pheromone in Aphids,” Science 196:680*681 (1977).

Feb. 28, 2000
Related US. Application Data

(62)

Back et al. “Cloning and Bacterial Expression of a Sesquit
erpene Cyclase from Hyoscyamus muticus and Its Molecular
Comparison to Related Terpene Cyclases,” J. Biol. Chem.
Bamby et al. “E?cects of Azadirachtin on Levels of Ecdys

U.S.C. 154(b) by 0 days.

(22) Filed:

315:527*532 (1994).

Pentalenene Synthase,” Arch. Biochem. Biophys.
254:421429 (1987).
Cane et al., “Pentalenene Synthase. Puri?cation, Molecular

Cloning, Sequencing, and HighiLevel Expression in
Escherichia coli of a Terpenoid Cyclase from Streptomyces

Int. Cl.
A01H 5/00
C12N 15/82

(2006.01)
(2006.01)

(52)

US. Cl. ...................................... .. 800/298; 435/419

(58)

Field of Classi?cation Search .............. .. 435/69.1,

435/320.1, 419; 536/232, 23.6; 800/278,
800/298

See application ?le for complete search history.

UC 5319,” Biochemistry 33:5846i5857 (1994).
Chappell et al., “Accumulation of Capsidiol in Tobacco Cell
Cultures Treated With Fungal Elicitor,” Phytochemistry
26:2259i2260 (1987).
Chappell, “Biochemistry and Molecular Biology of the
Isoprenoid Biosynthetic Pathway in Plants,” Annu. Rev.
Plant Physiol. Plant Mol. Biol. 46:52li547 (1995).
Chappell et al., “Is the Reaction Catalyzed by
3iHydroxyi3iMethylglutaryl Coenzyme A Reductase a

RateiLimiting Step for Isoprenoid Biosynthesis in Plants,”
(56)

References Cited
U.S. PATENT DOCUMENTS
5,744,341 A
5,824,774 A
6,072,045 A

W0
W0

4/1998 Cunningham, Jr. et al.
* 10/1998 Chappell et al. .......... .. 530/350
* 6/2000 Chappell et al. ......... .. 536/231

Plant Physiol. 109:1337*1343 (1995).
Chappell, “The Biochemistry and Molecular Biology of
Isoprenoid Metabolism,” Plant Physiol. 107:1*6 (1995).
Chen et al., “Cloning, Expression, and Characterization of

(+)io£adinene Synthase: A Catalyst for Cotton Phytoal
exin Biosynthesis,” Arch. Biochem. Biophys. 324:255i266

FOREIGN PATENT DOCUMENTS

(1995).

WO 94/22304
WO 95/11913

Chiu et al., “Engineered GFP as a vital reporter in plants,”

10/1994
5/1995

Current Biology 6:325*330 (1996).

OTHER PUBLICATIONS

(Continued)

Dudareva N. et al., The Plant Cell, May 2003, vol. 15, pp.

Primary ExamineriRussell P. Kallis
(74) Attorney, Agent, or FirmACataIyst Law Group, APC

1227*1241.*

Dudareva N. et al., The Plant Cell, May 2003, vol. 15, pp.
1227*1241.*

Schalk et al., PNAS, 97; (22); pp. 11948*11953.*
El Tamer, M et al., Arch. Biochem. Biophvs., 2003; vol. 411,
pp. 196*203.*
Alonso et al., “Puri?cation of 4SiLimonene Synthase, a

Monoterpene Cyclase from the Glandular Trichomes of

peppermint (Mentha x piperita) and Spearmint (Mentha
spicata),” J. Biol. Chem. 267:7582i7587 (1992).
Anke and Sterner, “Comparison of the Antimicrobial and

Cytotoxic Activities of Twenty Unsaturated Sesquiterpene

(57)

ABSTRACT

The invention features plant cells and plants that include a
nucleic acid molecule encoding a chimeric isoprenoid syn

thase polypeptide including an asymmetrically positioned
homologous domain. The chimeric isoprenoid synthases of
the invention catalyze the production of isoprenoid reaction
products that are not produced when the asymmetrically

positioned homologous domain is positioned at its naturally
occurring site in an isoprenoid synthase polypeptide.

Dialdehydes from Plants and Mushrooms,” Planta Med.

57:344i346 (1991).

23 Claims, 9 Drawing Sheets

US 7,186,891 B1
Page 2

Kalsi et al., “Stereostructures of TWo Biologically Active

OTHER PUBLICATIONS

Colby et al., “4SiLimonene Synthase from the Oil Glands of

Spearmint (Mentha spicata),”
268:23016*23024 (1993).

J.

Biol.

Chem.

Cortes et al., “Repositioning of a Domain in a Modular

Polyketide Synthase to Promote Speci?c Chain Cleavage,”
Science 268:1487A1489 (1995).
Croteau et al., “Biosynthesis of Monoterpenes: Partial Puri
?cation, Characterization, and Mechanism of Action of

1,8*Cineole Synthase,”
309:184*192 (1994).

Arch.

Biochem.

Biophys.

Dixon et al., “Phytoalexin Induction in French Bean,” Plant

Physiol. 71:251*256 (1983).
EliFeraly et al., “EPliDeoxyarteannuin B and 6,7iDehy
droartemisinic Acid from Artemisia Annua,” J. Nat. Prod.

52:196*198 (1989).
Elakovich, “Sesquiterpenes as Phytoalexins and Allelo

pathic Agents,” Ecology and Metabolism of Plant Lipids
325:93il08 (1986).

Sesquiterpene Lactones from Inula Racemosa,” Phytochem
istry 28:2093*2096 (1989).
Koepp et al., “Cyclization of Geranylgeranyl Diphosphate to
Taxa*4(5), 11(12)*diene Is the Committed Step of Taxol
Biosynthesis in Paci?c YeW,” J. Biol. Chem. 270:8686*8690

(1995).
Kubo et al., “Potentiation of antifungal activity of sesquit
erpene dialdehydes against Candida albicans and tWo other

fungi,” Experientia 48:1162*1164 (1992).
Kurosaki, “Dissociation of Dimeric 6*Hydroxymellein Syn
thase, a Polyketide Biosynthetic Enzyme in Carrot Cell
Extracts, With Loss of KetoiReducing Activity,” Archives of
Biochem. and Biophys. 321:239*244 (1995).
Lee et al., “Sesquiterpene Antitumor Agents: Inhibitors of
Cellular Metabolism,” Science 196: 533*536 (1977).
Mabry et al., “Sesquiterpene Lactones and Other Terpe
noids,” Herbivores, Their Interaction with Secondary Plant

Metabolites, 14:501*537 (1979).

Enzell et al., “Mass spectra of tobacco isoprenoids,” Mass

McDaniel et al., “Rational design of aromatic polyketide

Spectrometry Rev. 3:395 (1984).

natural products by recombinant assembly of enzymatic

Facchini et al., “Gene Family for an Elicitorilnduced Ses

subunits,” Nature 375:549i554 (1995).

quiterpene Cyclase in Tobacco,” Proc. Natl. Acad. Sci. USA
89:11088*11092 (1992).
Frohman et al., “Rapid production of fullilength cDNAs
from rare transcripts: Ampli?cation using a single geneispe
ci?c oligonucleotide primer,” Proc. Natl. Acad. Sci. USA
85:8998i9002 (1988).
Gambliel et al., “Pinene Cyclases I and II,” J. Biol. Chem.
259:740i748 (1984).
Gibson et al., “Wild potato repels aphids by release of aphid
alarm pheromone,” Nature 302:608*609 (1983).
Guo et al., “Biosynthesis of the Diterpene cisiAbienol in
CelliFree Extracts of Tobacco Trichomes,” Arch. Biochem.

Midland et al., “The Structure of Syringolides 1 and 2,
Novel CiGlycosidic Elicitors from Pseudomonas syringae
pv. tomato,” J. Org. Chem. 58:2940i2945 (1993).

Biophys. 308:103*108 (1994).
Habtermariam et al., “A NeW Antibacterial Sesquiterpene
From Premna Oligotricha,” J. Natl. Prod. 56:14(%143

(1993).
Hohn et al., “Isolation and nucleotide sequence of a sesquit

erpene cyclase gene from the trichotheceneiproducing fun
gus Fusarium sporotrichioides,” Gene 79:131*138 (1989).

Moesta et al., “Casbene Synthetase: Regulation of Phytoal
exin Biosynthesis in Ricinus communis L. Seedlings,”Arch.

Biochem. Biophys. 238:325i333 (1985).
Munck et al., “Puri?cation and Characterization of the

Sesquiterpene Cyclase Patchoulol Synthase from Pogoste
mon cablin,” Arch. Biochem. Biophys. 282:58i64 (1990).
Proctor et al., “Isolation, Characterization, and Bacterial

Expression of a Sesquiterpenoid Biosynthetic Gene (Aril)
from

Penicillium

Roqueforti,”

J.

Biol.

Chem.

268:4543i4548 (1993).
Russell et al., “A Sesquiterpenoid Ant Repellent from Dys

oxylum Spectabile,” Phytochemistry 35:1455*1456 (1994).
Ruzicka, “The Isoprene Rule and the Biogenesis of Terpenic

Compounds,” Experientia 10:357*396 (1953).

Hohn et al., “Purui?cation and Characterization of the

Savage et al., “Monoterpene Synthases of Pinus contorta and
Related conifers,” J Biol. Chem. 269:401241020 (1994).

Sesquiterpene Cyclase Aristolochene Synthase from Peni
cillium roqueforti” Arch. Biochem. Biophys. 272:137*143

That Trigger Plant Disease Resistance,” Tetrahedron Letters

(1989).

34:223i226 (1993).

Smith et al., “The syringolides: Bacterial CiGlycosyl Lipids

Hohn et al., “Puri?cation and Characterization of the Ses

Stevens, “Biological Activity and Chemistry of Sesquiter

quiterpene Cyclase Trichodiene Synthetase from Fusarium
sporotrichioides,” Arch. Biochem. Biophys. 251:756*761

pene Lactones,” Sesquiterpene Lactones pp. 65*80 (1984).

(1986).
Joly et al., “ElTect of SiteAlirected Mutagenesis of Con
served Asparate and Arginine Residues upon Famesyl

Diphosphate Synthase Activity,” J of Biol. Chem.
268:26983i26989 (1993).

Vogeli et al., “Puri?cation and Characterization of an Induc

ible Sesquiterpene Cyclase from ElicitoriTreated Tobacco
Cell Suspension Cultures,” Plant Physiol 93:182*187

(1990).
* cited by examiner

U.S. Patent

Mar. 6, 2007

US 7,186,891 B1

Sheet 1 0f 9

Y\\\\\\\\\\\\

mevoionote <— HMG-CoA
I

\

\

\

\ \

\

\

\

\

\

Classes
IPP —-> prenyl group

GPP

\

4-“ acetyl-CoA

\

Exomgles
cytokinin

Functions
_ growth regulator

aroma, fragrance,

~> monoterpenes

menthol

sesquiterpenes

copsidiol

plant—pothogen

sterols

compesterol

membrane structure

l
FPP

plant-insect interactions
interactions

and function

j

diterpenes gibbereliic acid,
,4

cosbene

GGPP \

growth regulator,
plant-pathogen
interactions

polyprenols

glycosylation,

dolichois,
ubiquinone,

electron transport,

carotenoids

photoprotection

Fig. 1

U.S. Patent

Mar. 6,2007

Sheet 5 0f 9

US 7,186,891 B1

Dominant
products

product.

,0

Fig. 4B

" "

U.S. Patent

Mar. 6, 2007

Sheet 6 0f 9

249
Exon 1, 2 & 3

368

4

5

US 7,186,891 B1

450

6

548 00

7

322

Hindlll Nde I
261

I512

Hinc II

379

Xba I
342

Clo l
442

COMMON DOMAINS
ARISTOLOCHENE SPECIFIC DOMAIN

RATIO DETERMINANT DOMAIN

,_.~:-;=_. VETISPIRADIENE SPECIFIC DOMAIN

U.S. Patent

Mar. 6,2007

Sheet 7 0m

/

REACTION
PRODUCTS

GENE CONSTRUCTS

TEAS

HI]
‘I?!’

1, 2, 3

5 \\\\\

ACTIVE

HVS

1,2,3.

Nde ]
261

CH3

1,2,3

0H1

7'
ACTIVE

2

Xba I
342

5 xx
ACTIVE

7

INACTIVE

s
INACTIVE

7'

lNACTlVE

1.2.3

1
INACTIVE

US 7,186,891 B1

INACTIVE

QQUIESCENT SYNTHASE}
Y

Fig. 6

U.S. Patent

Mar. 6, 2007

Sheet 8 0f 9

US 7,186,891 B1

REACTION
GENE CONSTRUCTS
——~__—__

/

OH]

1

2

3 §\\
INACTIVE

PRODUCTS
__—_—

\\

7

INACTIVE

l

(QUIESCENT SYNTHASE)

RC5

1

2

3

:

4

6

7

(CASBENE SYNTHASE)

\

\

\

\

/

Fig. 7

U.S. Patent

Mar. 6, 2007

Sheet 9 0f 9

CTI
DU
—_-_

GENE CONSTRUCTS

f

--—————

QH1 1

2

3

INACTIVE

5 INACTIVE
xx 7

[QUIESCENT SYNTHASE)

GCADS

1

2

3

US 7,186,891 B1

cam‘
:
:

4

5

6

7

(CADINENE SYNTHASE)

QCADS]
\

1

2

3 \\\\ 5 xx

7
J

US 7,186,891 B1
1

2

PLANT CELLS AND PLANTS EXPRESSING
CHIMERIC ISOPRENOID SYNTHASES

reactions, but this appears to be a common reaction among

isoprenoid biosynthetic enzymes and especially those
enzymes involved in catalyzing the cyclization of various

isoprenoid intermediates (Gershenzon and Croteau, In: Lipid

CROSS REFERENCE TO RELATED
APPLICATION

Metabolism in Plants, Moore, T. S., ed., CRC Press, Boca
Raton, Fla., pp. 3404388). The enzymes responsible for the

This application is a divisional of US. Ser. No. 09/134,
699, ?led Aug. 14, 1998, issued as US. Pat. No. 6,072,045
Which is a divisional of US. Ser. No. 08/631,341, ?ed Apr.

cyclization of GPP, FPP, and GGPP are referred to as

monoterpene, sesquiterpene, and diterpene synthases or
synthases, and represent reactions committing carbon from
the general isoprenoid pathWay to end products in the
monoterpene, sesquiterpene, and diterpene classes, respec

12, 1996 issued as US. Pat. No. 5,824,774.

tively.

STATEMENT AS TO FEDERALLY SPONSORED
RESEARCH

TWo important biochemical distinctions betWeen the pre
nyltransferase and synthase reactions are illustrated in FIG.

This invention Was made in part With Government

2. The prenyltransferases catalyze carbon-carbon bond for

funding, and the Government therefore has certain rights in

mation betWeen tWo substrate molecules, Whereas the syn
thases catalyze an intramolecular carbon-carbon bond for

the invention.

mation. The prenyltransferases also catalyze reactions With

BACKGROUND OF THE INVENTION

This invention relates to modi?ed isoprenoid synthase
enzymes, their encoding genes, and uses thereof.
The term isoprenoid is used to refer to a family of

very little variance in the stereochemistry or length of the

ensuing polymer. Prenyltransferases differ in the length of
20

compounds derived from the isoprene building block. In

utilize the same substrate to produce different reaction

particular, plant isoprenoids comprise a structurally diverse
group of compounds that can be divided into classes of

primary and secondary metabolites (FIG. 1). Isoprenoids

products.
25

that are primary metabolites include sterols, carotenoids,

groWth regulators, and the polyprenol substituents of
dolichols, quinones, and proteins. These compounds are
essential for membrane integrity, photoprotection, orches
tration of developmental programs, and anchoring essential
biochemical functions to speci?c membrane systems,

30

Fuller, G., and Tsai, L.-S., eds., Marcel Dekker, NeW York,
pp. 65480, 1984), plant-insect (Gibson and Pickett, Nature
3021608, 1983), and plant-pathogen interactions (Stoessl et

phillic attack betWeen the carbon bearing the diphosphate
moiety and the distal double bond to form germacene A, a
35

of the eudesmane carbonium ion constitutes step 2. For

at C9 giving rise to 5-epi-aristolochene as depicted in step
40

shares a common mechanism at steps 1 and 2, but differs

The common denominator for this diverse array of com

contraction Would occur due to alternative migration of an

electron pair. In each case, a monomeric protein of approxi
45

nalize the biosynthetic origins of all terpenoids derived from

isoprene (Ruzicka, Experientia 10:357, 1953). The polymer
(e.g., IPP and dimethylallyl) generates geranyl diphosphate
50

cyclic or linear end-products representing the monoterpenes,
(FPP), Which can also be converted to cyclic or linear
55

production of isoprenoid reaction products that are not
produced in the absence of the second domain of the second,

heterologous isoprenoid synthase. In preferred

the polymerization and chemical differentiation cycle leads
to the production of other classes of terpenoids named
according to the number of isoprene building blocks leading

embodiments, the chimeric isoprenoid synthase is capable of
catalyzing at least tWo different isoprenoid reaction prod
ucts; the isoprenoid reaction products are cyclic; the second

to their biosynthesis, for example, the addition of a third IPP

transferases that direct the attack of a carbocation (an
electron de?cient carbon atom resulting from the loss of the
diphosphate moiety of one substrate) to an electron-rich
carbon atom of the double bond on the IPP molecule (FIG.
2). The electrophilic nature of these reactions is said to be
unusual relative to more general nucleophilic condensation

In general, the invention features a chimeric isoprenoid
synthase polypeptide including a ?rst domain from a ?rst
isoprenoid synthase joined to a second domain from a

second, heterologous isoprenoid synthase, Whereby the chi
meric isoprenoid synthase is capable of catalyzing the

or used in another round of polymerization. The addition of

a third isoprene unit to GPP generates farnesyl diphosphate

to FPP generates geranylgeranyl diphosphate (GGPP).
These polymerization reactions are catalyzed by prenyl

mately 64 kD catalyzes the complete set of partial reactions
and requires no cofactors other than Mg+2.
SUMMARY OF THE INVENTION

ization of tWo diphosphorylated isoprene building blocks

products representing the sesquiterpene class. Continuing

3a. Hyoseyamus muticus vetispiradiene synthase (HVS)
from TEAS in the third partial reaction in Which a ring

pounds is their universal ?ve-carbon building block, iso

(GPP), a linear C10 intermediate that can be converted to

macrocylic intermediate. Internal ring closure and formation

tobacco 5-epi-aristolochene synthase (TEAS), the terminal
step is a hydride shift, methyl migration, and deprotonation

al., Phytochemistry 151855, 1976).
prene. The “biogenic isoprene rule” Was employed to ratio

The biosynthesis of isoprenoids such as cyclic terpenes is
said to be determined by key branch point enzymes referred
to as terpene synthases. The reactions catalyzed by terpene
synthases are complex, intramolecular cyclizations that may
involve several partial reactions. For example, the bioor
ganic rationale for the cyclization of FPP by tWo sesquiter
pene synthases are shoWn in FIG. 3. In step 1, the initial
ionization of FPP is folloWed by an intramolecular electro

respectively. Isoprenoids that are classi?ed as secondary

metabolites include monoterpenes, sesquiterpenes, and
diterpenes. These compounds are said to mediate important
interactions betWeen plants and their environment. For
example, speci?c terpenoids have been correlated With
plant-plant (Stevens, In: Isopentoids in Plants, Nes, W. D.

the allyic substrates that can be accepted in initiating these
reactions. The synthases are also substrate speci?c.
HoWever, diverse sesquiterpene synthases, for example, can

60

domain of the second, heterologous isoprenoid synthase also
determines the ratio of the isoprenoid reaction products of
the chimeric isoprenoid synthase; the ?rst domain from the

65

?rst isoprenoid synthase is a plant isoprenoid synthase and
the second domain from the second, heterologous isoprenoid
synthase is also from a plant isoprenoid synthase.
Preferably, the chimeric isoprenoid synthase is chosen
from the group consisting of (a) the tobacco-Hyoscyamus

US 7,186,891 B1
3

4

CH4 chimeric isoprenoid synthase; (b) the tobacco
Hyoscyamus CH10 chimeric isoprenoid synthase; (c) the
tobacco-Hyoscyamus CH11 chimeric isoprenoid synthase;
(d) the tobacco-Hyoscyamus CH12 chimeric isoprenoid
synthase; (e) the tobacco-Hyoscyamus CH13 chimeric iso
prenoid synthase; or (f) the tobacco-Hyoscyamus CH14

9118497, 1994; Chen et al., Arch. Biochem. Biophys.
3241255, 1994; and Cane et al., Biochemistry 3315846,
1 994).
By “polypeptide” or “protein” is meant any chain of

chimeric isoprenoid synthase, all as described herein.

amino acids, regardless of length or post-translational modi
?cation (for example, glycosylation or phosphorylation).
By “joined to” is meant covalently bonded either directly

In preferred embodiments, the chimeric isoprenoid syn
thase catalyzes the production of an isoprenoid reaction

ing amino acid sequence). Such domains may be bonded by

product that is of agricultural, pharmaceutical, commercial,

any means, including, Without limitation, a peptide bond or

or industrial signi?cance (e.g., an antifungal agent, antibac
terial agent, or antitumor agent).
In other related aspects, the invention features DNA,

chemical linkage.

or indirectly (i.e., the domains are separated by an interven

By “domain” is meant a contiguous stretch of amino acids
Within a polypeptide or protein.

vectors, and cells (for example, E. coli, Saccharomyces

By “isoprenoid” is meant a compound that is derived from
an isoprene building block. In particular, isoprenoid com

cerevisiae, animal or plant cells) encoding or containing a

chimeric isoprenoid synthase polypeptide.

pounds include, Without limitation, monoterpenes,

In another aspect, the invention features a chimeric iso

diterpenes, sesquiterpenes, and sterols. As described herein,

prenoid synthase polypeptide including an asymmetrically
positioned homologous domain Whereby the chimeric iso
prenoid synthase is capable of catalyZing the production of

isoprenoids are found in a variety of organisms, for example,
20

By “asymmetrically positioned” is meant located Within

isoprenoid reaction products (preferably, cyclic products)

the chimeric polypeptide at a site Which differs from its

When the domain is positioned at its naturally-occurring site

position in the naturally-occurring polypeptide.

in the isoprenoid synthase polypeptide.
In another aspect, the invention features a method for

25

producing a chimeric isoprenoid synthase polypeptide, the
method involving: (a) providing a cell transformed With
DNA encoding a chimeric isoprenoid synthase positioned
for expression in the cell; (b) culturing the transformed cell
under conditions for expressing the DNA; and (c) recovering

By “homologous” is meant derived from the same source

30

35

substrate) to an isoprenoid product (for example, a
monoterpene, diterpene, sesquiterpene, or sterol product).
Examples of such isoprenoid synthases include, Without

of terpene synthases from plant and microbial sources have
been isolated and characterized (see, for example, Moestra
and West, Arch. Biochem. Biophys. 2381325, 1985; Hohn
and Van MiddlesWorth, Arch. Biochem. Biophys. 2511756,
1986; Hohn and Plattner, Arch. Biochem. Biophys. 2721137,
1989; Cane and Pargellis, Arch. Biochem. Biophys. 2541421,
1987; Munck and Croteau, Arch. Biochem. Biophys. 282158,
1990; Alonso et al., J. Biol. Chem. 26717582, 1992; Savage
et al., J. Biol. Chem. 26914012, 1994; Croteau et al., Arch.

Biochem. Biophys. 3091184, 1994; Vogeli et al., Plant
Physiol. 931182, 1990; Guo et al., Arch. Biochem. Biophys.

40

arroWs indicate multiple steps or reactions.
FIG. 2 is a schematic illustration shoWing the various

reactions that are catalyZed by prenyltransferases and ter
FIG. 3 is a schematic illustration shoWing a reaction

mechanism for the synthesis of eremophilane (tobacco
45

5-epi-aristolochene synthase, TEAS) and vetispiradiene
(Hyoscyamus vetispiradiene synthase, HVS) type sesquit
erpene synthases. Partial reactions 1 and 2 are considered
common to both types of synthases. Mechanistic differences
in partial reactions 3a and 3b are suf?cient to account for the

50

different reaction products shoWn.
FIG. 4A is a schematic illustration shoWing the chimeric
constructs used to map catalytic domains Within sesquiter

pene synthases. Line draWings depict composite diagrams
55

for Wildtype (i.e., TEAS and HVS) and chimeric (CH1
CH14) sesquiterpene synthase genes that Were engineered
into the bacterial expression vector pGBT-T 19. Gene con
structs Were prepared using a combination of the available
restriction endonuclease sites and ampli?cation of select

regions using PCR and PCR primers harboring convenient
60

restriction endonuclease sites. Correspondence betWeen
unique restriction endonuclease sites and amino acid posi
tions are noted.

plant and microbial organisms (see, for example, Hohn and
Beremand, Gene 791131, 1989; Proctor and Hohn, J. Biol.
Chem. 26814543, 1993; Facchini and Chappell, Proc. Natl.
Acad. Sci. 89111088, 1992; Back and Chappell, J. Biol.
Chem. 27017375, 1995; Colby et al., J. Biol. Chem.
268123016, 1993; Mau and West, Proc. Natl. Acad. Sci.

The draWings Will ?rst be described.
FIG. 1 is a schematic illustration shoWing the isoprenoid

pene synthases.

3081103, 1994; and Gambliel and Croteau, J. Biol. Chem.
2591740, 1984). In general, terpene synthases are soluble
enZymes having a molecular Weight of about 40 to 100 kD.
Genes encoding a number of monoterpene, diterpene, and
sesquiterpene synthases have been described for a number of

embodiments thereof, and from the claims.

biosynthetic pathWay With respect to the type of end prod
ucts and their respective physiological functions. Broken

cadinene synthase) that are responsible for cycliZation of

geranyl diphosphate (GPP), farnesyl diphosphate (FPP), and
geranylgeranyl diphosphate (GGPP), respectively. Anumber

apparent from the folloWing description of the preferred
BRIEF DESCRIPTION OF THE DRAWINGS

capable of catalyZing a reaction involving the intramolecular
carbon-carbon bond formation of an allylic diphosphate

limitation, monoterpene synthases (for example, limonene
synthase), diterpene synthases (for example, casbene
synthase), and sesquiterpene synthases (for example, 5-epi
aristolochene synthase, vetispiradiene synthase, and

By “heterologous” is meant derived from different
sources (in this case, different polypeptides).
(in this case, the same polypeptide).
Other features and advantages of the invention Will be

the chimeric isoprenoid synthase.
By “isoprenoid synthase” is meant a polypeptide that is
substrate (for example, a C10, C15, or C2O allylic diphosphate

animal, fungal, or bacterial sources.

65

FIG. 4B is a photograph of a TLC experiment shoWing
synthase enZyme activities in sonicated lysates of E. coli
TB1 cells expressing the TEAS, HVS, and chimeric syn
thase constructs (CH1£H14) and measured using 3H-FPP.

Reaction products Were separated by argentation-TLC and
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5
detected by autoradiography. The radioactivity in 0.5 mm

CH5 Was prepared by ligating the 5' terminal portion of

segments of each lane of an argentation-TLC plate Was
determined in a scintillation counter, and radioactivity asso
ciated With the Zones for the TEAS and HVS speci?c
products Was set to 100%.
FIG. 5 is a schematic illustration showing the correspon
dence betWeen exons and functional domains Within iso

the HVS gene (corresponding to the EcoRI to HindIII

prenoid synthases. The upper diagram represents the orga

fragment) With the 3' terminal portion of TEAS gene
(corresponding to the NdeI to KpnI fragment) into pGBT

fragment) With the 3' terminal portion of TEAS gene
(corresponding to the HindIII to KpnI fragment) into pGBT
T19.

CH7 Was prepared by ligating the 5' terminal portion of
the HVS gene (corresponding to the EcoRI to NdeI

niZation of exons Within the TEAS gene, Which is nearly
identical to that of the HVS and casbene synthase genes. The

T19.

CH3, CH4, CH12, and CH13 Were constructed using

loWer diagram shoWs the alignment of functional domains to
the exonic organiZation of the TEAS and HVS genes. Exon

conventional polymerase chain reaction (PCR)
methodologies, With primers designed for the ampli?cation

numbers are shoWn Within the upper diagram, and all other
numbers refer to amino acid positions, some of Which
correspond to the noted restriction endonuclease sites.
FIG. 6 is a schematic diagram shoWing a domain sWitch

of particular segments of the HVS gene. To facilitate direc

tional cloning and maintenance of reading frame, primers
Were also designed to contain convenient restriction sites.
CH3 Was constructed as folloWs. An EcoRI/ClaI restric

ing strategy used to generate a quiescent synthase (QH1).
Substituting the inactive HVS domain corresponding to

tion fragment of the TEAS gene Was isolated and ligated to
the ClaI/KpnI fragment of the HVS gene. The HVS ClaI/

exon 4 into CH3 results in a synthase having an altered

enZyme activity.

20

(SEQ ID NO: 1; ClaI restriction site underlined) as the

strategy used for producing a chimeric quiescent-casbene

forWard primer and 5'-d(AATACGACTCACTATAG)-3'

synthase, and possible reaction products.
FIG. 8 is a schematic illustration of a domain sWitching

strategy for producing a chimeric quiescent-cadinene

(SEQ ID NO: 2) as the reverse primer (corresponding to the
25

T7 sequence found in the multiple cloning site of pBSK)
using pBSK-HVS as the DNA template. The resulting
restriction fragment Was ligated into the EcoRI/KpnI sites of
the pGBT-T19 vector.

30

using the forWard ampli?cation primers 5'-d(CGA
GTCAACATGGTTTATTGAGGGATA)-3' (SEQ ID NO: 3;

synthase, and possible reaction products.
DETAILED DESCRIPTION OF THE
INVENTION

Chimeric Isoprenoid Synthases

CH4 and CH13 Were constructed in a similar manner, but

Plasmids designed for expressing a chimeric synthase
Were generated by substituting a portion of a gene encoding

HincII restriction site underlined) and 5'-d(TAT
TCTAGATCTCTATGACGATTATGAA)-3' (SEQ ID NO:
4; XbaI restriction site underlined), respectively.

a domain from tobacco 5-epi-aristolochene synthase With a
portion of a gene encoding a domain from Hyoscyamus

vetispiradiene synthase. These plasmids Were expressed in
bacteria, and bacterial lysates Were prepared and assayed for

KpnI fragment Was prepared by PCR methodology using

5'-d(GGGATCGATGACATAGCCACGTATGAGGTT)-3'

FIG. 7 is a schematic diagram of a domain sWitching

35

CH12 Was prepared by ligating a PCR fragment corre
sponding to the ?rst 1326 nucleotides of CH4 With the

sesquiterpene synthase activity. The sesquiterpene synthase

ClaI/KpnI fragment of the TEAS gene into the EcoRI/KpnI

assays included an argentation-thin layer chromatography
(TLC) analysis Which distinguished the aristocholene and

prepared using forWard ampli?cation primer 5'-d

vetispiradiene reaction products (Back and Chappell, J. Biol.

sites of the pGBT-T19 vector. The CH4 fragment Was
40

(GGGAGCTC

Chem. 270:7375, 1995). As shoWn in FIG. 4A, fourteen

GAATTCCATGGCCTCAGCAGCAGTTGCAAACTAT)-3'

chimeric synthase constructs Were generated and Were
assayed as folloWs.

(SEQ ID NO: 5; EcoRI restriction site underlined and
translation start codon in bold) and reverse primer 5'-d(GGG

Full-length cDNAs for the tobacco 5-epi-aristolochene

synthase (TEAS) and Hyoscyamus vetispiradiene synthase

ATCGATAACTCTGCATAATGTAGCATT)-3' (SEQ ID
45

NO: 6; ClaI restriction site underlined).

(HVS) Were cloned into the EcoRI/Xhol sites of pBluescript

Chimeric synthases CH6, CH8, CH9, CH10, CH11, and

SK (Stratagene), creating the pBSK-TEAS and pBSK-HVS
plasmids, respectively (Back and Chappell, J. Biol. Chem.

CH14 Were constructed as folloWs. Ligation of the EcoRI/

270:7375, 1995). The TEAS and HVS cDNA inserts ofthese
expression plasmids Were oriented With their translation start
codons neighboring the EcoRI restriction site and their 3'
poly A tail ?anked by the Xhol restriction site of the pSK

50

EcoRI/NdeI fragment of CH5 With the NdeI/KpnI fragment

plasmid.
Chimeric synthases CH1, CH2, CH5, and CH7 Were
constructed by utiliZing the conserved HindIII and NdeI
restriction sites found betWeen the tobacco and Hyoscyamus
genes. CH1 Was prepared by ligating the 5' terminal portion

of HVS. CH10 Was constructed by ligating the EcoRI/

HindIII fragment of HVS With the HindIII/KpnI fragment of
55

60

Corp).

CH2 Was prepared by ligating the 5' terminal portion of
the TEAS gene (corresponding to the EcoRI to NdeI

T19.

SK-HVS. The nucleotide junctions of the chimeric con
structs Were con?rmed by double-stranded DNA sequencing

using the dideoxy nucleotide chain termination kit, accord
ing to the manufacturer’s instructions (U.S. Biochemical

bacterial expression vector pGBT-T19 (Gold
Biotechnology) predigested With EcoRI and KpnI.
fragment) With the 3' terminal portion of HVS gene
(corresponding to the NdeI to KpnI fragment) into pGBT

CH4. CH11 Was constructed by ligating the EcoRI/NdeI

fragment of HVS With the NdeI/KpnI fragment of CH4. And
CH14 Was generated by substituting the EcoRI/NdeI frag
ment of CH13 With the corresponding DNA fragment of pB

of the TEAS gene (corresponding to the EcoRI to HindII

fragment) With the 3' terminal portion of HVS gene
(corresponding to the HindIII to KpnI fragment) into the

HindIII fragment of the HVS gene With the HindIII/KpnI
fragment of CH3 generated CH6. CH8 Was created by
ligating the EcoRI/NdeI fragment of HVS With the NdeI/
KpnI fragment of CH3. CH9 Was created by ligating the

65

Chimeric synthases Were expressed in E. coli TB1 cells.
Procedures for groWth of the bacterial cells, induction of

gene expression, measurement of sesquiterpene synthase
enZyme activity, and the determination of total protein in the
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bacterial lysates Were performed according to the methods

to HincII fragment of the cDNA), While amino acids 379 to
442 Within the Hyoscyamus protein are responsible for the

described by Back and Chappell (Arch. Biochem. Biophys.
315:527, 1994; J. Biol. Chem. 270:7375, 1995). Reaction
products Were separated by developing G60 silica TLC

HVS-speci?c products (i.e., the region corresponding to the
HincII to ClaI fragment of the cDNA).
Our interpretation Was con?rmed by evaluating the
expression products of CH11 and CH12. CH11 represented
the substitution of the NdeI to HincII fragment of the
Hyoscyamus gene With the corresponding tobacco gene
fragment, and resulted in the production of an enzyme
having HVS- and TEAS-speci?city. CH12 represented a
substitution of the HincII to ClaI fragment of the tobacco
gene With the corresponding Hyoscyamus gene fragment,
and resulted in the production of an enzyme having HVS
and TEAS-speci?city. Comparing CH11 to CH13 provided

plates impregnated With 15% silver nitrate in benzenezhex

ane:diethyl ether (50: 50: 1). For qualitative evaluations, TLC
plates Were sprayed With Enhance surface ?uorography
spray (Dupont) and exposed to Kodak XAR-5 ?lm for 2 to
5 days at —700 C. For quantitative evaluations, 0.5 mm zones
of an entire lane from a TLC plates Were scraped into
scintillation vials, and the radioactivity Was determined
using a Packard 1500 Liquid Scintillation Counter. The

dominant reaction products generated by the synthase activi
ties resulting from expression of the TEAS, HVS, CH4, and
CH14 constructs in bacterial lysates Were also veri?ed by

a further re?nement in the domain characterization of the

gas chromatography (GC) and gas chromatography-mass
spectroscopy (GC-MS) according to the conditions
described by Chappell et al. (Phylochemislry 26:2259, 1987)

tobacco enzyme responsible for the TEAS-speci?c products.
The fact that CH13 Was found to be a multifunctional

enzyme indicated that the 81 amino acids encoded by the
DNA fragment residing betWeen the NdeI to XbaI restriction

(data not shoWn). In addition, mass spectra pro?les Were

compared to that published for 5-epi-aristolochene (Anke
and Sterner, Planla Med. 57:344, 1991) and the predicted
fragmentation pattern for vetispiradiene (Enzell et al., Mass

20

Was con?rmed by substituting the domain contained Within
the NdeI/XbaI HVS cDNA restriction fragment of CH14
With that of the TEAS gene (FIG. 4A).

Spectrometry Rev. 3:395, 1984).
As shoWn in FIGS. 4AiB, the dominant reaction product
resulting from the expression of the tobacco TEAS gene
expressed Was 5-epi-aristolochene, and vetispiradiene Was
found to be the dominant reaction product resulting from the
expression of the HVS gene. The predominant reaction
products generated by the expression of CH1 and CH2 Were

also HVS-speci?c (i.e., vetispiradiene), With enzyme spe

sites of the tobacco cDNA Were su?icient for formation of

the predominant TEAS speci?c products. This interpretation

25

As shoWn in FIG. 4B, the predominant reaction product(s)
of the Wildtype tobacco TEAS and Hyoscyamus HVS genes
expressed in bacteria migrated on silver nitrate-TLC plates
With Rf values of 0.41 and 0.31, values consistent With
previous characterization of these products as 5-epi

30

aristolochene and vetispiradiene, respectively (Back and

ci?c activities similar to those found for HVS that Was

Chappell, J. Biol. Chem. 270:7375, 1995; Back et al., Arch.

expressed from the pBSK-HVS plasmid. These results indi

Biochem. Biophys. 3152527, 1994). GC and GC-MS analy

cated that the amino-terminal half of TEAS and HVS Were

ses indicated that the predominant TEAS reaction products
Were 5-epi-aristolochene (70% of total products, based on
percentage of total peak areas from GC analysis) and a

functionally equivalent With respect to the HVS carboxy
terminus and do not contribute to the speci?city of the
reaction product. CH7, having an HVS amino terminus and

35

bicyclic sesquiterpene (20%) ([M]+ ion at m/z of 204). The
predominant HVS reaction product Was vetispiradiene

a TEAS carboxy terminus, is the converse construct of CH2,

and the resulting synthase activity Was expected to result in

expression of a TEAS-speci?c product (i.e., 5-epi
aristolochene). Immunodetection assays revealed that syn
thase protein produced upon expression of CH7 Was found
to be of the correct size and expected abundance (data not
shoWn); hoWever, no enzyme activity Was detected. The lack
of enzyme activity indicated that interactions betWeen the
carboxy and amino terminal portions of the protein contrib
uted to enzyme activity. This interpretation is further sup

40

(>90%) ([M]+ ion at m/z of 204 With a base peak at m/z 41
and a series ofpredictable ions at m/z 175, 108, 94, and 68),
and the predominant reaction products of CH4 Were 5-epi

aristolochene (18%), a bicyclic sesquiterpene (43%), and

vetispiradiene (32%) (data not shoWn).
In addition, studies relying on a?inity puri?cation of
histidine-tagged recombinant synthase proteins has revealed
45

?ve other minor reaction products, each representing
approximately 1% of the total products, With all ?ve found

ported by comparing the speci?c activity of the enzymes

at the same relative abundance in all the reaction assays.

generated by the expression of the CH5 and CH6 constructs.
CH5 resulted in the expression of a product having a 10-fold

Ratio-Determinant Domain

loWer speci?c activity of synthase enzyme activity than the

50

products produced by the multifunctional chimeric synthase
enzymes (FIG. 4A). For example, the reaction products
resulting from expression of constructs CH4, CH10, CH11,

other chimeric synthases, even though the absolute level of
expressed protein Was similar to the other constructs (as

determined by immunodetection, data not shoWn). Substi
tuting an HVS carboxy-terminal region Was found to restore
the speci?c activity to the synthase enzyme that Was gen

and CH12 Were generated in a ratio of 60*70% TEAS
55

erated by CH6.
Comparison of CH2 and CH3 chimeric synthases pro
vided evidence for speci?city of end-product formation
residing Within a domain of approximately 181 amino acids,
corresponding to the NdeI and ClaI restriction sites Within
the TEAS and HVS genes. Expression of CH4 unexpectedly
resulted in the production of a chimeric synthase protein

speci?c to 30*40% HVS-speci?c. In contrast, an inverse
ratio of reaction products resulted from expression of con
structs CH13 and CH14. This result indicated that the region
encompassed by the XbaI to HincII domain in?uenced the

relative ratio of reaction products generated by the multi
60

functional chimeric synthase enzymes. These results indi
cated that tWo separate and distinct domains Within the

synthase peptide contributed directly to the types of reaction
products generated, and are interrupted by another domain

capable of generating reaction products re?ective of both the
TEAS and HVS enzymes. We interpreted this result to
indicate that amino acids 261 to 379 Within the tobacco

Another domain of the synthase proteins Was identi?ed by
comparing the relative ratio of the predominant reaction

Which We refer to as the ratio-determinant domain (FIG. 5).

5-epi-aristolochene synthase are responsible for the TEAS

Site-Directed Mutagenesis
Additional analysis of the product speci?city and ratio

speci?c products (i.e., the region corresponding to the NdeI

determinant domains Was determined using conventional

65
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Quiescent Synthases

site-directed mutagenesis methodologies. The results of this
analysis are presented in Table I (below). For example, the
DDXXD motif, found Within the aristolochene speci?c

To generate a quiescent synthase, the inactive domain
corresponding to exon 4 of HVS is substituted With the
corresponding active domain of CH3, as outlined in FIG. 6.
CH3 contains an inactive domain corresponding to exon 6 of
TEAS, has convenient NdeI and XbaI restriction sites for the
desired substitution, and can be overexpressed in bacteria to

domain, is a conserved sequence that is found in a variety of

terpene biosynthetic enzymes including TEAS and HVS.
This acidic amino acid cluster is said to coordinate a metal

cofactor that is necessary to neutralize the diphosphate
moiety of FPP in an otherWise lipophilic pocket. Substitu
tion of the ?rst aspartic acid residue (D301) of the DDXXD

high levels. Domain sWitching is accomplished using stan

motif With either glutamic acid (overall charge conservation)

particular example, a PCR ampli?cation product of HVS

or valine (net loss of acidic charge) residues (i.e., D301—>E

cDNA corresponding to exon 4, encompassing amino acids
261 to 342 and containing appropriate NdeI and XbaI sites
Within the primers, is substituted for the corresponding
region of CH3. In generating such constructs, care is exer
cised to maintain appropriate amino acid residues and the
correct reading frame, and expression testing of the con

dard molecular techniques, as described herein. In one

and D301QV) resulted in the formation of an inactivated
enzyme. A conserved substitution of the second aspartic acid

(D302) With a glutamic acid residue (i.e., D302—>E) also
inactivated chimeric synthase enzyme activity by 95%, and
resulted in a slight alteration of the product distribution of
the multifunctional enzyme.

struct entails a measurement of the protein level in the

TABLE I
Product ratio
Mutation

Mutated

Aristo-

target gene

amino acid

lochene piradiene

CH4

66%

Vetis-

Speci?c
Activity

(nmol/mg hi1)

34%

D301V

out using TLC, and comparing the Rf values of the experi

34
25

Substrate binding domain (Ndel/Xbal region)
Tobacco

20

No

R287A

CH4

D301V

CH4

D301E

CH4

D302E

No

germacrene or germacrene-like reaction product) are also

0

monitored using GC, GC-MS, and NMR according to stan
dard methods.

activity
No

0

30

activity
No

0

activity
51%

49%

1.8

Ratio determinant domain (Xbal/HincII region)
35
CH4
CH4
CH4

K347I
H360S
H364S

64%
63%
65%

36%
32%
35%

32
29
38

CH4

T408A
K420M
H422A
N436S

67%
68%
67%
70%

33%
32%
33%
30%

48
29
30
32

AT437,

61%

39%

33

40

sesquiterpene synthase that catalyzes the synthesis of a
45

The sites for directed substitutions Within the ratio

To construct such chimeric casbene and cadienne
50

synthases, quiescent amino terminal domains (and other
synthase domains as necessary) are substituted With those

from casbene and cadinene synthase using convenient

differences in comparisons betWeen the TEAS and HVS
primary sequences. None of the three mutations analyzed
had any effect on overall catalytic activity or the ratio of

Amino acid substitutions Within the HVS speci?c domain
Were chosen on the basis of comparisons betWeen secondary
structural predictions of the HVS and TEAS proteins. Those
amino acids mutated appeared to contribute disproportion
ately to structural distortions in the secondary structure

bicyclic sesquiterpene, provide domains useful for engineer
ing enzymes capable of producing macrocylic isoprenoids or
isoprenoid reaction products having altered sterochemical
properties. A general scheme for producing such chimeric
synthases is presented in FIGS. 7 and 8.

determinant domain (i.e., K347QI, H360QS, H364QS)
Were inferred by an analysis of reports that hypothesized the
importance of charged amino acid residues (e.g., histidine or

products formed.

synthases such as casbene synthase, a diterpene synthase
Which catalyzes the synthesis of a macrocyclic diterpene
harboring a cyclopropyl side group, and cadiene synthase, a

43 8VI

lysine) in synthase enzymology, and these sites represented
those amino acids Which displayed the greatest charge

The quiescent synthase is useful for providing sufficient
amounts of the germacrene reaction intermediate(s) (or
derivatives thereof) to con?rming the chemical rationaliza
tion for the EAS and VS reactions, and produces a template
chimeric synthase that may be used for the introduction of
novel terminal steps in the overall synthase reaction scheme.
Chimeric Casbene and Cadinene Synthases
Chimeric isoprenoid synthases are also useful for gener

ating novel macrocyclic isoprenoids or isoprenoids having
altered stereochemical properties. For example, isoprenoid

Hyoscyalnus speci?c domain (HincII/ClaI region)
CH4
CH4
CH4
CH4

mental sample to those generated by the TEAS and HVS
enzymes. Retention times of the reaction products (e.g.,

0

activity
CH4

soluble and insoluble fractions of bacterial lysates by immu
noblotting techniques, as Well as by enzyme assays.
In addition, large scale enzyme reactions are performed,
the reaction product(s) are extracted into hexane, and the
products are puri?ed by HPLC methods. Additional evalu
ation of the quiescent enzyme reaction products is carried

restriction sites and PCR ampli?cation of selected regions as
described above. Sequences corresponding to the
55

N-terminal, plastid targeting sequence of the casbene syn
thase are deleted in these constructs. Chimeric constructs are

expressed in bacteria, bacterial lysates are examined for
chimeric synthase activity, and reaction products are char
acterized as described above, for example, using
60

models of these tWo proteins, largely because of charge
considerations. HoWever, as shoWn in Table I (above),

substitutions involving charged to non-charged (i.e.,

argentation-TLC. Constructs supporting high levels of syn
thase activity in bacteria and/or activity generating reaction
products Which migrate With Rfs different from aris

overall enzyme activity, nor the synthesis rate of one product

tolochene and vetispiradiene standards are considered useful
in the invention. Reaction products are also analyzed for
their retention times by GC and subjected to GC-MS and
NMR, as necessary. Those domains of casbene synthase and

or the other.

cadinene synthase Which contribute to the synthesis of

T408—>A, K420—>M, H422—>A) or reduced charged
(N436—>S, A437—>T, V438—>I) amino acids did not affect

65
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unique reaction products may also be subjected to ?ne detail
mapping using a strategy analogous to that depicted in FIG.

edness to the synthase polypeptide family may be accom

plished by a variety of conventional methods, for example,
sequence comparison. In addition, the activity of any syn

4A.

Production of Other Chimeric Isoprenoid Synthases
Using the standard molecular techniques described
herein, other chimeric synthases may be readily generated

thase protein may be evaluated according to any of the

techniques described herein.

Chimeric Isoprenoid Synthase Polypeptide Expression

Which include domains from knoWn or neWly isolated

Chimeric synthase polypeptides may be produced by

synthase enZymes. Such chimeric synthases may be tested

transformation of a suitable host cell With all or part of a

for activity using, for example, any appropriate enZyme

chimeric synthase DNA (for example, the chimeric synthase

assays knoWn to those in the art, or by standard immuno

cDNAs described above) in a suitable expression vehicle or

detection techniques.

or a portion of the amino acid sequence of a knoWn synthase

With a plasmid construct engineered for increasing the
expression of a chimeric synthase polypeptide in vivo.
Those skilled in the ?eld of molecular biology Will
appreciate that any of a Wide variety of expression systems
may be used to provide the recombinant protein. The precise

polypeptide, one may readily design synthase-speci?c oli

host cell used is not critical to the invention. The chimeric

gonucleotide probes, including synthase degenerate oligo

synthase protein may be produced in a prokaryotic host, for
example, E. coli TB1, or in a eukaryotic host, for example,

The isolation of additional synthase coding sequences is

also possible using standard cloning strategies and tech
niques that are Well knoWn in the art. For example, using all

nucleotide probes (i.e., a mixture of all possible coding
sequences for a given amino acid sequence). These oligo
nucleotides may be based upon the sequence of either DNA

strand and any appropriate portion of synthase nucleotide
sequence. General methods for designing and preparing
such probes are provided, for example, in Ausubel et al.,
1996, Current Protocols in Molecular Biology, Wiley
Interscience, NeW York, and Berger and Kimmel, Guide to
Molecular Cloning Techniques, 1987, Academic Press, NeW

Saccharomyces cerevisiae, mammalian cells (for example,
20

including, Without limitation, algae, tree species, ornamental
species, temperate fruit species, tropical fruit species, veg
etable species, legume species, monocots, dicots, or in any
25

plant of commercial or agricultural signi?cance. Particular
examples of suitable plant hosts include, but are not limited

to, Conifers, Petunia, Tomato, Potato, Tobacco, Arabidopsis,
Lettuce, Sun?ower, Oilseed rape, Flax, Cotton, Sugarbeet,

York. These oligonucleotides are useful for synthase gene
isolation, either through their use as probes capable of
hybridiZing to a synthase complementary sequences or as

primers for various ampli?cation techniques, for example,
polymerase chain reaction (PCR) cloning strategies.
Hybridization techniques and screening procedures are

COS 1 or NIH 3T3 cells), or any of a number of plant cells

30

Celery, Soybean, Alfalfa, Medicago, Lotus, Vigna,
Cucumber, Carrot, Eggplant, Cauli?ower, Horseradish,
Morning Glory, Poplar, Walnut, Apple, Asparagus, Rice,
Maize, Millet, Onion, Barley, Orchard grass, Oat, Rye, and
Wheat.

Well knoWn to those skilled in the art and are described, for

Such cells are available from a Wide range of sources

example, in Ausubel et al. (supra); Berger and Kimmel
(supra); Chen at al. Arch. Biochem. Biophys. 324:255, 1995;
and Sambrook et al., Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Laboratory Press, NeW York. If
desired, a combination of different oligonucleotide probes

including: the American Type Culture Collection (Rockland,
35

W. Atlee Burpee Seed Co. (Warminster, Pa.), Park Seed Co.

(Greenwood, SC), Johnny Seed Co. (Albion, Me.), or

Northrup King Seeds (Harstville, S.C.). Descriptions and

may be used for the screening of a recombinant DNA library.

The oligonucleotides may be detectably-labeled using meth

sources of useful host cells are also found in Vasil I. K., Cell
40

ods knoWn in the art and used to probe ?lter replicas from
a recombinant DNA library. Recombinant DNA libraries are

Culture and Somatic Cell Genetics ofPlants, Vol I, II, III
Laboratory Procedures and Their Applications Academic
Press, NeW York, 1984; Dixon, R. A., Plant Cell Culture-A

Practical Approach, IRL Press, Oxford University, 1985;

prepared according to methods Well knoWn in the art, for
example, as described in Ausubel et al. (supra), or they may
be obtained from commercial sources.

Md.); or from any of a number seed companies, for example,

45

Green et al., Plant Tissue and Cell Culture, Academic Press,
NeW York, 1987; and Gasser and Fraley, Science 244: 1293,

As discussed above, synthase oligonucleotides may also
be used as primers in ampli?cation cloning strategies, for

(1989).

example, using PCR. PCR methods are Well knoWn in the art

synthase polypeptide is carried on a vector operably linked

and are described, for example, in PCR Technology, Erlich,
ed., Stockton Press, London, 1989; PCR Protocols: A Guide
to Methods and Applications, Innis et al., eds., Academic
Press, Inc., NeW York, 1990; and Ausubel et al. (supra).
Primers are optionally designed to alloW cloning of the
ampli?ed product into a suitable vector, for example, by
including appropriate restriction sites at the 5' and 3' ends of
the ampli?ed fragment (as described herein). If desired, a
synthase gene may be isolated using the PCR “RACE”
technique, or Rapid Ampli?cation of cDNA Ends (see, e.g.,

For prokaryotic expression, DNA encoding a chimeric

50

contain, at its 5' end, a sequence encoding any of the knoWn

55

strains of E. coli; hoWever, other microbial strains may also

origins, selectable markers, and control sequences derived
from a species compatible With the microbial host.
60

Examples of such vectors are found in PouWels et al. (supra)

or Ausubel et al. (supra). Commonly used prokaryotic
control sequences (also referred to as “regulatory elements”)

directions and are used to generate overlapping PCR frag
ments. These overlapping 3'- and 5'-end RACE products are
combined to produce an intact full-length cDNA. This
method is described in Innis et al. (supra); and Frohman et

al., Proc. Natl. Acad. Sci. USA 8518998, (1988).
Useful synthase sequences may be isolated from any
appropriate organism. Con?rmation of a sequence’s relat

signal sequences capable of e?fecting secretion of the
expressed protein into the periplasmic space of the host cell,
thereby facilitating recovery of the protein and subsequent
puri?cation. Prokaryotes most frequently used are various
be used. Plasmid vectors are used Which contain replication

Innis et al. (supra)). By this method, oligonucleotide primers
based on a synthase sequence are oriented in the 3' and 5'

to control signals capable of e?fecting expression in the
prokaryotic host. If desired, the coding sequence may

are de?ned herein to include promoters for transcription
65

initiation, optionally With an operator, along With ribosome
binding site sequences. Promoters commonly used to direct
protein expression include the beta-lactamase

(penicillinase), the lactose (lac), the tryptophan (Trp)

US 7,186,891 B1
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(Goeddel et al., Nucl. Acids Res. 814057 (1980)), and the tac

Alternatively, if desired, a chimeric synthase polypeptide
is produced by a stably-transfected mammalian cell line. A

promoter systems, as Well as the lambda-derived PL pro

moter and N-gene ribosome binding site (Simatake et al.,
Nature 292:128 (1981)).
One particular bacterial expression system for chimeric
synthase polypeptide production is the E. coli pET expres

number of vectors suitable for stable transfection of mam
malian cells are available to the public, e.g., see PouWels et

al. (supra); methods for constructing such cell lines are also
publicly available, e.g., in Ausubel et al. (supra). In one

example, cDNA encoding the chimeric synthase polypeptide

sion system (Novagen). According to this expression
system, DNA encoding a chimeric synthase polypeptide is

is cloned into an expression vector Which includes the

dihydrofolate reductase (DHFR) gene. Integration of the
plasmid and, therefore, the chimeric synthase-encoding gene

inserted into a pET vector in an orientation designed to alloW

expression. Since the chimeric synthase gene is under the
control of the T7 regulatory signals, expression of chimeric
synthase is induced by inducing the expression of T7 RNA
polymerase in the host cell. This is typically achieved using
host strains Which express T7 RNA polymerase in response
to lPTG induction. Once produced, recombinant chimeric
synthase polypeptide is then isolated according to standard
methods knoWn in the art, for example, those described

into the host cell chromosome is selected for by inclusion of
0.0li300 uM methotrexate in the cell culture medium (as
described in Ausubel et al., supra). This dominant selection
can be accomplished in most cell types. Recombinant pro

tein expression can be increased by DHFR-mediated ampli
?cation of the transfected gene. Methods for selecting cell
lines bearing gene ampli?cations are described in Ausubel et

al. (supra); such methods generally involve extended culture
in medium containing gradually increasing levels of meth
otrexate. DHFR-containing expression vectors commonly

herein.

Another bacterial expression system for chimeric syn

thase polypeptide production is the pGEX expression system
(Pharmacia). This system employs a GST gene fusion sys
tem that is designed for high-level expression of a gene or
gene fragment as a fusion protein With rapid puri?cation and
recovery of the functional gene product. The chimeric

synthase protein of interest is fused to the carboxyl terminus
of the glutathione S-transferase protein from Schistosoma

20

the host cells described above or, preferably, a DHFR

de?cient CHO cell line (for example, CHO DHFR-cells,
25

japonicum and is readily puri?ed from bacterial lysates by
af?nity chromatography using Glutathione Sepharose 4B.
elution With glutathione. Cleavage of the glutathione
30

Wels et al. (supra), Weissbach and Weissbach (supra), and
Gelvin et al. (supra). Methods for constructing such cell
lines are described in, e.g., Weissbach and Weissbach
35

or transfection and the choice of vehicle for expression of

the chimeric synthase polypeptide Will depend on the host
system selected. Transformation and transfection methods of
numerous organisms, for example, the baker’s yeast Sac
charomyces cerevisiae, are described, e.g., in Ausubel et al.

(supra); Weissbach and Weissbach, Methods for Plant
Molecular Biology, Academic Press, 1989; Gelvin et al.,
Plant Molecular Biology Manual, KluWer Academic
Publishers, 1990; Kindle, K., Proc. Natl. Acad. Sci. USA
8711228 (1990); Potrykus, 1., Annu. Rev. Plant Physiol.
Plant Mol. Biology 42:205 (1991); and BioRad (Hercules,
Calif.) Technical Bulletin #1687 (Biolistic Particle Delivery
Systems). Expression vehicles may be chosen from those
provided, e.g., in Cloning Vectors: A Laboratory Manual (P.
H. PouWels et al., 1985, Supp. 1987); Gasser and Fraley

by a stably-transfected plant cell line or by a transgenic
plant. A number of vectors suitable for stable transfection of
plant cells or for the establishment of transgenic plants are
available to the public; such vectors are described in Pou

upstream of this domain. For example, proteins expressed in
pGEX-2T plasmids may be cleaved With thrombin; those
expressed in pGEX-3X may be cleaved With factor Xa.
For eukaryotic expression, the method of transformation

ATCC Accession No. CRL 9096) are among the host cells
preferred for DHFR selection of a stably-transfected cell line
or DHFR-mediated gene ampli?cation.

A chimeric synthase polypeptide is preferably produced

Fusion proteins can be recovered under mild conditions by

S-transferase domain from the fusion protein is facilitated by
the presence of recognition sites for site-speci?c proteases

used for this purpose include pCVSEll-DHrF and

pAdD26SV(A) (described in Ausubel et al., supra). Any of

(supra), and Gelvin et al. (supra). Typically, plant expression
vectors include (1) a cloned chimeric synthase gene under
the transcriptional control of 5' and 3' regulatory sequences

40

and (2) a dominant selectable marker. Such plant expression
vectors may also contain, if desired, a promoter regulatory
region (for example, one conferring inducible or constitutive
expression, or environmentally- or developmentally
regulated, or pathogen- or Wound-inducible, or cell- or

45

tissue-speci?c expression), a transcription initiation start
site, a ribosome binding site, an RNA processing signal, a
transcription termination site, and/or a polyadenylation sig

50

nal.
The chimeric synthase DNA sequence of the invention
may, if desired, be combined With other DNA sequences in
a variety of Ways. The chimeric synthase DNA sequence of
the invention may be employed With all or part of the gene

(supra); Clontech Molecular Biology Catalog (Catalog

sequences normally associated With a synthase protein. In its

1992/93 Tools for the Molecular Biologist, Palo Alto,
Calif.); and the references cited above.
One preferred eukaryotic expression system is the mouse

component parts, a DNA sequence encoding a chimeric
synthase protein is combined in a DNA construct having a

3T3 ?broblast host cell transfected With a pMAMneo

transcription initiation control region capable of promoting
55

LTR enhancer linked to a dexamethasone-inducible MMTV

LTR promotor, an SV40 origin of replication Which alloWs
replication in mammalian systems, a selectable neomycin
gene, and SV40 splicing and polyadenylation sites. DNA
encoding a chimeric synthase polypeptide is inserted into the

60

functional fragment thereof Will be joined at its 5' end to a

transcription initiation regulatory region such as the
sequence naturally found in the 5' upstream region of a
synthase structural gene. Numerous other transcription ini
tiation regions are available Which provide for constitutive

pMAMneo vector in an orientation designed to alloW

expression. The recombinant chimeric synthase polypeptide
is then isolated as described beloW. Other preferable host

cells Which may be used in conjunction With the pMAMneo
expression vehicle include COS cells and CHO cells (ATCC
Accession Nos. CRL 1650 and CCL 61, respectively).

transcription and translation in a host cell.

In general, the constructs Will involve regulatory regions
functional in plants Which provide for production of a
chimeric synthase protein as discussed herein. The open
reading frame coding for the chimeric synthase protein or

expression vector (Clontech). pMAMneo provides: an RSV

65

or inducible regulation.

For applications When developmental, cell, tissue,
hormonal, environmental, or pathogen-inducible expression

US 7,186,891 B1
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are desired, appropriate 5' upstream non-coding regions are
obtained from other genes; for example, from genes regu

1:839 (1989)); and pathogen-inducible gene expression
described by Chappell et al. in US. Ser. Nos. 08/471,983,

lated during seed development, embryo development, leaf

08/443,639, and 08/ 577,483, hereby incorporated by refer

development, or in response to a pathogen.

ence.

Regulatory transcript termination regions may also be

Plant expression vectors may also optionally include

provided in DNA constructs of this invention as Well.

RNA processing signals, for example, introns, Which have

Transcript termination regions may be provided by the DNA

been shoWn to be important for ef?cient RNA synthesis and
accumulation (Callis et al., Genes and Dev. 1:1183 (1987)).
The location of the RNA splice sequences can dramatically
in?uence the level of transgene expression in plants. In vieW
of this fact, an intron may be positioned upstream or
doWnstream of a chimeric synthase polypeptide-encoding

sequence encoding a synthase protein or any convenient
transcription termination region derived from a different
gene source. The transcript termination region Will contain
preferably at least 143 kb of sequence 3' to the structural
gene from Which the termination region is derived. Such
genetically-engineered plants are useful for a variety of
industrial and agricultural applications as discussed beloW.
lmportantly, this invention is applicable to gymnosperms
and angiosperms, and Will be readily applicable to any neW
or improved transformation or regeneration method.
An example of a useful plant promoter according to the
invention is a caulimovirus promoter, for example, a cauli

?oWer mosaic virus (CaMV) promoter. These promoters
confer high levels of expression in most plant tissues, and
the activity of these promoters is not dependent on virally

sequence in the transgene to modulate levels of gene expres
sion.

20

encoded proteins. CaMV is a source for both the 35S and

19S promoters. In most tissues of transgenic plants, the
CaMV 35S promoter is a strong promoter (see, e.g., Odell et
al., Nature 313:810 (1985)). The CaMV promoter is also

highly active in monocots (see, e.g., Dekeyser et al., Plant
Cell 2:591 (1990); Terada and Shimamoto, Mol. Gen. Genet.
220:389, (1990)). Moreover, activity of this promoter can be
further increased (i.e., betWeen 2410 fold) by duplication of
the CaMV 35S promoter (see e.g., Kay et al., Science
236:1299 (1987); OW et al., Proc. Natl. Acad. Sci. USA.
84:4870 (1987); and Fang et al., Plant Cell 1:141 (1989)).
Other useful plant promoters include, Without limitation,

the nopaline synthase promoter (An et al., Plant Physiol.
88:547 (1988)) and the octopine synthase promoter (Fromm

monly used terminators are derived from the octopine or
25

nopaline synthase signals.
The plant expression vector also typically contains a
dominant selectable marker gene used to identify those cells
that have become transformed. Useful selectable genes for

30

plant systems include genes encoding antibiotic resistance
genes, for example, those encoding resistance to

hygromycin, kanamycin, bleomycin, G418, streptomycin, or
spectinomycin. Genes required for photosynthesis may also
be used as selectable markers in photosynthetic-de?cient

strains. Alternatively, the green-?uorescent protein from the
35

jelly?sh Aequorea victoria may be used as a selectable

marker (Sheen et al., Plant J. 8:777, 1995; Chiu et al.,

Current Biology 6:325 (1996)). Finally, genes encoding

et al., Plant Cell 1:977 (1989)).
For certain applications, it may be desirable to produce
the chimeric synthase gene product in an appropriate tissue,
at an appropriate level, or at an appropriate developmental

In addition to the aforementioned 5' regulatory control
sequences, the expression vectors may also include regula
tory control regions Which are generally present in the 3'
regions of plant genes (Thomburg et al., Proc. Natl. Acad.
Sci. USA. 84:744 (1987); An et al., Plant Cell 1:115
(1989)). For example, the 3' terminator region may be
included in the expression vector to increase stability of the
mRNA. One such terminator region may be derived from the
Pl-ll terminator region of potato. In addition, other com

herbicide resistance may be used as selectable markers;
useful herbicide resistance genes include the bar gene
40

encoding the enZyme phosphinothricin acetyltransferase and

time. For this purpose, there are an assortment of gene

conferring resistance to the broad spectrum herbicide

promoters, each With its oWn distinct characteristics embod

Basta® (Hoechst AG, Frankfurt, Germany).

ied in its regulatory sequences, shoWn to be regulated in
response to the environment, hormones, and/or developmen

Ef?cient use of selectable markers is facilitated by a
determination of the susceptibility of a plant cell to a
particular selectable agent and a determination of the con

tal cues. These include gene promoters that are responsible

45

for heat-regulated gene expression (see, e.g., Callis et al.,
Plant Physiol. 88:965 (1988); Takahashi and Komeda, Mol.

centration of this agent Which effectively kills most, if not
all, of the transformed cells. Some useful concentrations of
antibiotics for tobacco transformation include, e.g., 754100

Gen. Genet. 219:365 (1989); and Takahashi et al. Plant J.

2:751 (1992)), light-regulated gene expression (e.g., the pea
rbcS-3A described by Kuhlemeier et al. (Plant Cell 1:471

50

(1989); the maiZe rbcS promoter described by Schalfner and
Sheen, (Plant Cell 3:997 (1991); or the chlorophyll a/b
binding protein gene found in pea described by Simpson et
al. (EMBO J. 4:2723 (1985)), hormone-regulated gene

expression (for example, the abscisic acid (ABA) responsive

formants for herbicide resistance is described, e.g., by Vasil
et al., supra.
It should be readily apparent to one skilled in the art of
55

sequences from the Em gene of Wheat described by Marcotte
et al. (Plant Cell 1:969 (1989); the ABA-inducible HVAl

and HVA22, and the rd29A promoters described for barley
and Arabidopsis by Straub et al. (Plant Cell 6:617 (1994),
Shen et al. (Plant Cell 7:295 (1994)), and Wound-induced

ug/ml (kanamycin), 20450 ug/ml (hygromycin), or 5410
ug/ml (bleomycin). A useful strategy for selection of trans

molecular biology, especially in the ?eld of plant molecular
biology, that the level of gene expression is dependent, not
only on the combination of promoters, RNA processing
signals, and terminator elements, but also -on hoW these
elements are used to increase the levels of selectable marker

gene expression.
60

Plant Transformation

gene expression (for example, of Wunl described by SiebertZ

Upon construction of the plant expression vector, several

et al. (Plant Cell 1:961 (1989)), or organ-speci?c gene

standard methods are available for introduction of the vector

expression (for example, of the tuber-speci?c storage pro

into a plant host, thereby generating a transgenic plant.
These methods include (1) Agrobacterium-mediated trans
formation (A. tumefaciens or A. rhizogenes) (see, e.g., Lich
tenstein and Fuller ln: Genetic Engineering, vol 6, P W J

tein gene described by Roshal et al. (EMBO J. 6:1155
(1987); the 23-kDa Zein gene from maiZe described by
Schemthaner et al. (EMBO J. 7:1249 (1988); or the French
bean [3-phaseolin gene described by Bustos et al. (Plant Cell
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Rigby, ed, London, Academic Press, 1987; and Lichtenstein,

US 7,186,891 B1
17

18

C. P., and Draper, 1,. In: DNA Cloning, Vol II, D. M. Glover,

fully cultured to regenerate an entire plant; such techniques

ed, Oxford, IRI Press, 1985)), (2) the particle delivery

are described, e.g., in Vasil supra; Green et al., supra;
Weissbach and Weissbach, supra; and Gelvin et al., supra.
In one particular example, a cloned chimeric synthase

system (see, e.g., Gordon-Kamm et al., Plant Cell 2:603
(1990); or BioRad Technical Bulletin 1687, supra), (3)

polypeptide under the control of the EAS4 promoter and the
nopaline synthase terminator and carrying a selectable

microinjection protocols (see, e.g., Green et al., supra), (4)
polyethylene glycol (PEG) procedures (see, e.g., Draper et

marker (for example, kanamycin resistance) is transformed

al., Plant Cell Physiol. 23:451 (1982); or e.g., Zhang and

into Agrobacterium. Transformation of leaf discs (for
example, of tobacco leaf discs), With vector-containing

Wu, Theor Appl. Genet. 76:835 (1988)), (5) liposome
mediated DNA uptake (see, e.g., Freeman et al., Plant Cell

Agrobacterium is carried out as described by Horsch et al.
(Science 227:1229 (1985)). Putative transformants are
selected after a feW Weeks (for example, 3 to 5 Weeks) on

Physiol. 25:1353 (1984)), (6) electroporation protocols (see,
e.g., Gelvin et al., supra; Dekeyser et al., supra; Fromm et

al., Nature 319:791 (1986); Sheen, Plant Cell 2:1027
(1990); or Jang and Sheen Plant Cell 6: 1 665 (1994)), and (7)
the vortexing method (see, e.g., Kindle supra). The method

plant tissue culture media containing kanamycin (e.g., 100
ug/ml). Kanamycin-resistant shoots are then placed on plant
tissue culture media Without hormones for root initiation.

of transformation is not critical to the present invention. Any
method Which provides for ef?cient transformation may be

Kanamycin-resistant plants are then selected for greenhouse
groWth. If desired, seeds from self-fertilized transgenic

employed. As neWer methods are available to transform

crops or other host cells, they may be directly applied.
The following is an example outlining one particular
technique, an Agrobacterium-mediated plant transforma

tion. By this technique, the general process for manipulating

plants can then be soWed in soil-less medium and groWn in
a greenhouse. Kanamycin-resistant progeny are selected by
soWing surfaced steriliZed seeds on hormone-free
20

genes to be transferred into the genome of plant cells is
carried out in tWo phases. First, cloning and DNA modi?
cation steps are carried out in E. coli, and the plasmid
containing the gene construct of interest is transferred by

conjugation or electroporation into Agrobacterium. Second,
the resulting Agrobacterium strain is used to transform plant
cells. Thus, for the generaliZed plant expression vector, the
plasmid contains an origin of replication that alloWs it to
replicate in Agrobacterium and a high copy number origin of
replication functional in E. coli. This permits facile produc
tion and testing of transgenes in E. coli prior to transfer to

for example, Ausubel et al. supra; Gelvin et al. supra).

Transgenic plants expressing the selectable marker are
then screened for transmission of the transgene DNA by
standard immunoblot and DNA detection techniques. Each
25

30

screened for each transgene to identify and select plants With
the most appropriate expression pro?les.
35

on the vector are restriction endonuclease sites for the
addition of one or more transgenes and directional T-DNA

border sequences Which, When recognized by the transfer
functions of Agrobacterium, delimit the DNA region that
40

In another example, plant cells may be transformed by
shooting into the cell tungsten microprojectiles on Which
cloned DNA is precipitated. In the Biolistic Apparatus
(Bio-Rad) used for the shooting, a gunpoWder charge (22
caliber PoWer Piston Tool Charge) or an air-driven blast

drives a plastic macroprojectile through a gun barrel. An
aliquot of a suspension of tungsten particles on Which DNA
has been precipitated is placed on the front of the plastic
macroprojectile. The latter is ?red at an acrylic stopping
plate that has a hole through it that is too small for the
macroprojectile to pass through. As a result, the plastic

45
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DNA introduced into the cell on the microprojectiles
becomes integrated into either the nucleus or the chloroplast.

Transgenic lines are generally evaluated for levels of
transgene expression. Expression at the RNA level is deter

mined initially to identify and quantitate expression-positive
plants. Standard techniques for RNA analysis are employed
and include PCR ampli?cation assays using oligonucleotide
primers designed to amplify only transgene RNA templates
and solution hybridization assays using transgene-speci?c
probes (see, e.g., Ausubel et al., supra). The RNA-positive
plants are then analyZed for protein expression by Western
immunoblot analysis using speci?c antibodies to the chi
meric synthase (see, e.g., Ausubel et al., supra). In addition,
in situ hybridiZation and immunocytochemistry according to
standard protocols can be done using transgene-speci?c
nucleotide probes and antibodies, respectively, to localiZe
sites of expression Within transgenic tissue.
Once the recombinant chimeric synthase protein is
expressed in any cell or in a transgenic plant (for example,
as described above), it may be isolated, e.g., using affinity
chromatography. In one example, an anti-chimeric synthase
antibody (e.g., produced as described in Ausubel et al.,

macroprojectile smashes against the stopping plate, and the
tungsten microprojectiles continue toWard their target
through the hole in the plate. For the present invention, the
target can be any plant cell, tissue, seed, or embryo. The

tissue and developmental patterns of transgene expression.
Consequently, a number of transgenic lines are usually

Resistance genes can be carried on the vector, one for

Will be transferred to the plant.

positive transgenic plant and its transgenic progeny are
unique in comparison to other transgenic plants established
With the same transgene. Integration of the transgene DNA
into the plant genomic DNAis in most cases random, and the
site of integration can profoundly effect the levels and the

Agrobacterium for subsequent introduction into plants.
selection in bacteria, for example, streptomycin, and another
that Will function in plants, for example, a gene encoding
kanamycin resistance or herbicide resistance. Also present

kanamycin-containing media. Analysis for the integration of
the transgene is accomplished by standard techniques (see,

supra, or by any standard technique) may be attached to a
55

column and used to isolate the polypeptide. Lysis and
fractionation of chimeric synthase-producing cells prior to

af?nity chromatography may be performed by standard

In general, transfer and expression of transgenes in plant

methods (see, e.g., Ausubel et al., supra). Once isolated, the
recombinant protein can, if desired, be further puri?ed, for

cells are noW routine practices to those skilled in the art, and

example, by high performance liquid chromatography (see,

have become major tools to carry out gene expression
agricultural or commercial interest.

e.g., Fisher, Laboratory Techniques In Biochemistry And
Molecular Biology, eds., Work and Burdon, Elsevier, 1980).
These general techniques of polypeptide expression and

Transgenic Plant Regeneration

puri?cation can also be used to produce and isolate useful

studies in plants and to produce improved plant varieties of

chimeric synthase fragments or analogs. Use

Plants cells transformed With plant expression vectors can

be regenerated, for example, from single cells, callus tissue,
or leaf discs according to standard plant tissue culture
techniques. It is Well knoWn in the art that various cells,
tissues, and organs from almost any plant can be success

The invention described herein is useful for a variety of
65

agricultural, pharmaceutical, industrial, and commercial
purposes. For example, the methods, DNA constructs,

proteins, and transgenic organisms, including the bacteria,

